YoungBok Ko

Prof. YoungBok Ko

Chungnam University Hospital
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2021 in Foods
Verified
Journal Article
Open access
PDF file
YYYoungsang You
Youngsang You
MLMuci Li
Muci Li
TKTaiyoung Kang
Taiyoung Kang
YKYoungBok Ko
YoungBok Ko
SKSangoh Kim
Sangoh Kim
SJSoojin Jun
Soojin Jun
Freezing extends the shelf-life of food by slowing down the physical and biochemical reactions; however, ice crystal formation can result in irreversible damage to the cell’s structure and texture. Supercooling technology has the potential to preserve the original freshness of food without freezing damage. In this study, fresh asparagus was preserved in a supercooled state and its quality changes such as color, weight loss, texture, chlorophyll and anthocyanin content, and enzymatic activities (superoxide dismutase and catalase) were evaluated. The asparagus samples were successfully supercooled at −3 °C with the combination treatment of pulsed electric field (PEF) and oscillating magnetic field (OMF), and the supercooled state was maintained for up to 14 days. Asparagus spears preserved in the supercooled state exhibited lower weight loss and higher levels of quality factors in comparison to the frozen and refrigerated control samples.

29 September 2017 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
MLMina Lee
Mina Lee
YKYoungBok Ko
YoungBok Ko
JYJung‐Bo Yang
Jung‐Bo Yang
BKByung Hun Kang
Byung Hun Kang

26 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SHSukhwan Hyun
Sukhwan Hyun
JYJigeun Yoo
Jigeun Yoo
YJYewon Jung
Yewon Jung
WSWonkyo Shin
Wonkyo Shin
SSSOO YOUN SONG
SOO YOUN SONG
HYHeon Jong Yoo
Heon Jong Yoo
Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.

25 February 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LJLee Jaehyung
Lee Jaehyung
YKYoungBok Ko
YoungBok Ko
YCYong Min Choi
Yong Min Choi
JKJinju Kim
Jinju Kim
HCHwan-Doo Cho
Hwan-Doo Cho
JYJae-Min Yuk
Jae-Min Yuk
Sepsis, a leading cause of death worldwide, is a harmful inflammatory condition that is primarily caused by an endotoxin released by Gram-negative bacteria. Effective targeted therapeutic strategies for sepsis are lacking. In this study, using an in vitro and in vivo mouse model, we demonstrated that CM1, a derivative of the natural polyphenol chrysin, exerts an anti-inflammatory effect by inducing the expression of the ubiquitin-editing protein TNFAIP3 and the NAD-dependent deacetylase sirtuin 1 (SIRT1). Interestingly, CM1 attenuated the Toll-like receptor 4 (TLR4)-induced production of inflammatory cytokines by inhibiting the extracellular-signal-regulated kinase (ERK)/MAPK and nuclear factor kappa B (NF-κB) signalling pathways. In addition, CM1 induced the expression of TNFAIP3 and SIRT1 on TLR4-stimulated primary macrophages; however, the anti-inflammatory effect of CM1 was abolished by the siRNA-mediated silencing of TNFAPI3 or by the genetic or pharmacologic inhibition of SIRT1. Importantly, intravenous administration of CM1 resulted in decreased susceptibility to endotoxin-induced sepsis, thereby attenuating the production of pro-inflammatory cytokines and neutrophil infiltration into the lung compared to control mice. Collectively, these findings demonstrate that CM1 has therapeutic potential for diverse inflammatory diseases, including sepsis.

3 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
LJLee Jaehyung
Lee Jaehyung
YKYoungBok Ko
YoungBok Ko
YCYong Min Choi
Yong Min Choi
JKJinju Kim
Jinju Kim
HCHwan-Doo Cho
Hwan-Doo Cho
JYJae-Min Yuk
Jae-Min Yuk
Human sepsis is one of the leading cause of death worldwide and is known to be a harmful damaging host inflammatory condition, primarily caused by endotoxin released by gram-negative bacteria. Despite antibiotics administration being widely used to treat disease, effective targeted therapeutic strategies for the sepsis are still lacking. Here, we demonstrate that CM1, a derivative of natural polyphenol chrysin, exerts anti-inflammatory activity by inducing the ubiquitin-editing protein TNFAIP3 and NAD-dependent deacetylase sirtuin 1 (SIRT1). We found that CM1 attenuated Toll-like receptor 4 (TLR4)-induced the generation of inflammatory cytokines by inhibiting the extracellular-signal-regulated kinase (ERK)/MAPK and nuclear factor kappa B (NF-κB) signaling pathway. In addition, the treatment of macrophages with CM1 induced the expression of TNFAIP3 and SIRT1 in TLR4-stimulated primary macrophages, however the anti-inflammatory properties of CM1 was disappeared by siRNA silencing of TNFAPI3 or by the genetic and pharmacologic inhibition of SIRT1. Importantly, intravenously administration of CM1 resulted in the decreased susceptibility to endotoxin-induced sepsis, leading to inhibition of the generation of proinflammatory cytokines and neutrophils infiltration into lung than control mice. Collectively, these findings suggest that CM1 has the potential to be a treatment candidate for diverse inflammatory diseases including sepsis.

13 March 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
URUmanthi Ranaraja
Umanthi Ranaraja
EKEun Young Kim
Eun Young Kim
DKD. Chanuka M. Kulatunga
D. Chanuka M. Kulatunga
RKRyoung Eun Kim
Ryoung Eun Kim
JHJin Woo Ham
Jin Woo Ham
MKM. K. Kim
M. K. Kim